SCHEMBL29453797

SCHEMBL29453797

N#CC1(Cc2ccccc2C(F)(F)F)CCN(C(=O)c2cccnc2-c2ccncc2)CC1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 7/20 0.56
▸ CYP3A4 P08684 2/20 0.56
▸ CYP2C8 P10632 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ CYP2C19 P33261 1/20 0.56
▸ PKLR P30613 1/20 0.41
▸ RBP4 P02753 2/20 0.39
▸ EPHX2 P34913 2/20 0.39
▸ SCD O00767 1/20 0.38
▸ KCNH2 Q12809 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ P2RX7 Q99572 1/20 0.37
▸ HSD11B1 P28845 1/20 0.37
▸ SLC6A7 Q99884 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22719295 1.00 CYP46A1 (0.56) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453793 0.92 CYP46A1 (0.51) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL24709774 0.92 CYP46A1 (0.51) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719183 0.90 CYP46A1 (0.51) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453766 0.90 CYP46A1 (0.51) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22728298 0.90 CYP46A1 (0.43) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719363 0.89 CYP46A1 (0.58) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453760 0.89 CYP46A1 (0.58) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL22719460 0.88 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19
SCHEMBL29453711 0.88 CYP46A1 (0.59) CYP46A1CYP3A4CYP2C8CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976186-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Sage Therapeutics, Inc. (US) 2022-04-06 — — EP disclosed
Send feedback